Melanoma vaccine reduces death risk by 42 per cent
A new personalised melanoma cancer vaccine developed through research led by former Australian Of The Year Professor Georgina Long has shown a 42 per cent reduction in death and recurrence risk. The Moderna vaccine works by re-educating the immune system to recognise and attack cancer cells, and is administered in combination with checkpoint inhibitors that help T cells destroy cancer cells.
See omnystudio.com/listener for privacy information.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.